Intranasal Civamide for Episodic Cluster Headache

Last updated: June 8, 2011
Sponsor: Winston Laboratories
Overall Status: Completed

Phase

3

Condition

Acute Pain

Chronic Pain

Pain

Treatment

N/A

Clinical Study ID

NCT00069082
WL-1001-02-05
  • Ages > 18
  • All Genders

Study Summary

This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).

Eligibility Criteria

Inclusion

  • At least 2 year history of episodic cluster headache (meeting IHS criteria)

  • At least 2 previous episodes

  • Expected duration of cluster period is at least 6 weeks but not longer than 24 weeks

  • At least 1 but not more than 8 headaches on each of the 3 days immediately prior to treatment

Study Design

Total Participants: 2
Study Start date:
August 01, 2003
Estimated Completion Date:
January 31, 2004

Connect with a study center

  • San Francisco Clinical Research Center

    San Francisco, California
    United States

    Site Not Available

  • California Medical Clinic for Headache

    Santa Monica, California
    United States

    Site Not Available

  • Colorado Neurology and Headache Clinic

    Denver, Colorado 80218
    United States

    Site Not Available

  • Diamond Headache Clinic

    Chicago, Illinois
    United States

    Site Not Available

  • New York Headache Center

    New York, New York
    United States

    Site Not Available

  • Cleveland Clinic Foundation

    Cleveland, Ohio
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.